Health Care Equipment & Services

Insider buying spiked at Adagio Medical Holdings, revealing confidence in its ablation tech and potential for near‑term value growth.

CEO Nassif Mikheal’s recent Neogen share purchase signals quiet confidence in the company’s growth and a value‑buying strategy, offering investors insight into future upside.

HeartBeam’s new RSU and option grants to non‑employee directors signal board confidence in its telemedicine growth strategy—watch earnings, partnerships, and FDA milestones to gauge real upside.

Insider buying at QTREX Quantum shows CEO Ben‑Noon Dagi Shahar’s confidence amid a 104% monthly rally, boosting his stake to 3.6 M shares and signaling potential upside for value investors.

Insider sale of 20,400 OWLET shares by CEO Workman Kurt amid a steep price decline signals a liquidity‑driven move, not a bearish outlook, and highlights the company’s ongoing challenge to build confidence in a value‑based, digital‑health market.

CEO Sim Brandon’s recent Astrana Health share sale is a routine liquidity move, not a red flag, amid steady stock gains and solid fundamentals.

HealthEquity insider selling: What Ladd Delano’s 1,080‑share sale and similar moves by top execs mean for investors and market sentiment.

Astra Health insider sale shows routine tax‑planning, not a shift in strategy—insiders stay invested while the company pushes digital therapeutics and population health gains.

Explore how L1 Capital’s 12% stake jump in Anteris Technologies could boost liquidity, signal institutional confidence, and spark a price rebound amid AI‑powered healthcare innovation.

Insider buying of Nakamoto Inc. shares sparks optimism amid a reverse split and governance overhaul, hinting at a potential rebound and new growth.